BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 361136)

  • 1. Recirculation of prostacyclin (PGI2) in the dog.
    Dusting GJ; Moncada S; Vane JR
    Br J Pharmacol; 1978 Oct; 64(2):315-20. PubMed ID: 361136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of prostacyclin (PGI2) on tissues which detect prostaglandins (PG'S).
    Omini C; Moncada S; Vane JR
    Prostaglandins; 1977 Oct; 14(4):625-32. PubMed ID: 339280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of prostacyclin generation for modulation of vascular tone.
    Dusting GJ; Moncada S; Mullane KM; Vane JR
    Clin Sci Mol Med Suppl; 1978 Dec; 4():195s-198s. PubMed ID: 365431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II stimulation of renal prostaglandin synthesis elevates circulating prostacyclin in the dog.
    Shebuski RJ; Aiken JW
    J Cardiovasc Pharmacol; 1980; 2(5):667-77. PubMed ID: 6157958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relaxation by prostacyclin (PGI2) and 7-oxo-PGI2 of isolated cerebral, coronary and mesenteric arteries.
    Malomvölgyi B; Hadházy P; Magyar K; Kánai K; Simonidesz V
    Acta Physiol Acad Sci Hung; 1982; 60(4):251-6. PubMed ID: 6764858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass-spectrometric evidence for spontaneous and angiotensin-induced generation of prostacyclin by perfused cat lungs.
    Palonek E; Korbut R; Gryglewska T; Gryglewski RJ
    Prostaglandins; 1980 Dec; 20(6):993-1006. PubMed ID: 7010452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostacyclin (PGI2) release accompanying angiotensin conversion in rat mesenteric vasculature.
    Dusting GJ; Mullins EM; Nolan RD
    Eur J Pharmacol; 1981 Mar; 70(2):129-37. PubMed ID: 7021169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of prostacyclin (PGI2) and 6-oxo-PGF1 alpha in anaesthetized dogs.
    Salmon JA; Mullane KM; Dusting GJ; Moncada S; Vane JR
    J Pharm Pharmacol; 1979 Aug; 31(8):529-32. PubMed ID: 39993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostacyclin (PGI2) induces coronary vasodilatation in anaesthetised dogs.
    Dusting GJ; Chapple DJ; Hughes R; Moncada S; Vane JR
    Cardiovasc Res; 1978 Dec; 12(12):720-30. PubMed ID: 376143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimultion by angiotensin of prostacyclin biosynthesis in rats and dogs.
    Dusting GJ; Mullins EM
    Clin Exp Pharmacol Physiol; 1980; 7(5):545-50. PubMed ID: 7004681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostacyclin (PGI2) decreases the cyclic AMP level in coronary arteries.
    Schrör K; Rösen P
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Jan; 306(1):101-3. PubMed ID: 218118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological evaluation of 5-(Z,E)-13,14-didehydro-20-methyl-carboprostacyclin (FCE 22509).
    Ceserani R; Grossoni M; Ukmar G; Colombo M; Mongelli N
    Prostaglandins Leukot Med; 1986 Mar; 21(3):231-45. PubMed ID: 3517883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of the mechanisms involved in the fate of prostacyclin (PGI2) and 6-keto-PGF1alpha in the pulmonary circulation.
    Hawkings HJ; Smith JB; Nicolaou KC; Eling TE
    Prostaglandins; 1978 Dec; 16(6):871-84. PubMed ID: 219443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotransformation and cardiovascular effects of arachidonic acid in the dog.
    Mullane KM; Dusting GJ; Salmon JA; Moncada S; Vane JR
    Eur J Pharmacol; 1979 Mar; 54(3):217-28. PubMed ID: 428423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disappearance of prostacyclin (PGI2) in the circulation of the dog [proceedings].
    Dusting GJ; Moncada S; Vane JR
    Br J Pharmacol; 1978 Mar; 62(3):414P-415P. PubMed ID: 346132
    [No Abstract]   [Full Text] [Related]  

  • 16. Differences in the stability of prostacyclin in human, rabbit and rat plasma.
    El Tahir KE; Williams KI; Betteridge DJ
    Prostaglandins Leukot Med; 1983 Feb; 10(2):109-14. PubMed ID: 6342001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary and systemic vasodilator effects of the newly discovered prostaglandin, PGI2.
    Kadowitz PJ; Chapnick BM; Feigen LP; Hyman AL; Nelson PK; Spannhake EW
    J Appl Physiol Respir Environ Exerc Physiol; 1978 Sep; 45(3):408-13. PubMed ID: 359514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular relaxing activity and stability studies of 10,10-difluoro-13,14-dehydroprostacyclin.
    Hatano Y; Kohli JD; Goldberg LI; Fried J; Mehrotra MM
    Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6846-50. PubMed ID: 7005902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
    Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
    Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the rabbit transverse stomach-strip to identify and assay prostacyclin, PGA2, PGD2 and other prostaglandins.
    Whittle BJ; Mugridge KG; Moncada S
    Eur J Pharmacol; 1979 Jan; 53(2):167-72. PubMed ID: 759196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.